| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
103,000,000 |
| Market
Cap: |
453.20(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$1.99 - $4.97 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Humacyte is engaged in the development and manufacture of off-the-shelf, universally implantable, bioengineered human tissues. Co. is utilizing its technology platform to develop proprietary, bioengineered, acellular human tissues for use in the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
4,750 |
198,275 |
| Total Buy Value |
$0 |
$0 |
$19,855 |
$784,399 |
| Total People Bought |
0 |
0 |
1 |
6 |
| Total Buy Transactions |
0 |
0 |
1 |
14 |
| Total Shares Sold |
0 |
0 |
33,422,190 |
40,807,494 |
| Total Sell Value |
$0 |
$0 |
$94,707,915 |
$120,632,535 |
| Total People Sold |
0 |
0 |
4 |
4 |
| Total Sell Transactions |
0 |
0 |
22 |
37 |
| End Date |
2024-02-01 |
2023-10-31 |
2023-05-02 |
2022-05-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Scheessele William John |
Chief Commercial Officer |
• – – |
2022-12-13 |
4 |
B |
$3.09 |
$15,450 |
D/D |
5,000 |
15,525 |
2.74 |
20% |
|
| Niklason Laura E |
President, CEO and Director |
• • • |
2022-12-13 |
4 |
S |
$2.84 |
$937,200 |
I/I |
(330,000) |
18,600,004 |
|
-20% |
|
| Prichard Heather Ledbetter |
Chief Operating Officer |
• – – |
2022-12-12 |
4 |
OE |
$1.15 |
$7,549 |
D/D |
6,564 |
9,189 |
|
- |
|
| Niklason Laura E |
President, CEO and Director |
• • • |
2022-09-15 |
4 |
S |
$4.00 |
$6,090,000 |
I/I |
(1,522,500) |
18,930,004 |
|
32% |
|
| Dougan Brady W |
Director |
– • • |
2022-09-15 |
4 |
S |
$4.00 |
$6,090,000 |
I/I |
(1,522,500) |
18,930,004 |
|
32% |
|
| Ayabudge Llc |
10% Owner |
– – • |
2022-09-15 |
4 |
S |
$4.00 |
$6,090,000 |
D/D |
(1,522,500) |
18,930,004 |
|
32% |
|
| Niklason Laura E |
President, CEO and Director |
• • • |
2022-09-15 |
4 |
B |
$4.14 |
$8,280 |
D/D |
2,000 |
1,160,240 |
3.15 |
-32% |
|
| Dougan Brady W |
Director |
– • • |
2022-09-15 |
4 |
B |
$4.14 |
$8,280 |
I/I |
2,000 |
1,160,240 |
2.17 |
-32% |
|
| Binder Gordon M |
Director |
– • – |
2022-09-02 |
4 |
B |
$4.40 |
$272,100 |
D/D |
61,841 |
110,000 |
2.39 |
-41% |
|
| Binder Gordon M |
Director |
– • – |
2022-09-01 |
4 |
B |
$4.00 |
$192,636 |
D/D |
48,159 |
48,159 |
2.39 |
-40% |
|
| Scheessele William John |
Chief Commercial Officer |
• – – |
2022-05-24 |
4 |
B |
$4.72 |
$49,678 |
D/D |
10,525 |
10,525 |
2.74 |
-29% |
|
| Dougan Brady W |
Director |
– • • |
2022-05-23 |
4 |
B |
$4.83 |
$48,300 |
I/I |
10,000 |
1,158,240 |
2.25 |
-32% |
|
| Niklason Laura E |
President, CEO and Director |
• • • |
2022-05-23 |
4 |
B |
$4.83 |
$48,300 |
D/D |
10,000 |
1,158,240 |
3.23 |
-32% |
|
| Constantino Michael T. |
Director |
– • – |
2022-05-23 |
4 |
B |
$4.83 |
$9,660 |
D/D |
2,000 |
4,500 |
2.39 |
-32% |
|
| Sander Dale A. |
CFO and Chief Corp. Deve. Off. |
• – – |
2022-05-17 |
4 |
B |
$4.53 |
$9,060 |
D/D |
2,000 |
2,000 |
2.74 |
-27% |
|
| Dougan Brady W |
Director |
– • • |
2021-12-16 |
4 |
S |
$9.00 |
$675,000 |
D/D |
(75,000) |
510,161 |
|
15% |
|
| Niklason Laura E |
President, CEO and Director |
• • • |
2021-12-16 |
4 |
S |
$9.00 |
$675,000 |
I/I |
(75,000) |
510,161 |
|
15% |
|
| Dougan Brady W |
Director |
– • • |
2021-12-15 |
4 |
S |
$8.89 |
$1,110,625 |
D/D |
(125,000) |
585,161 |
|
18% |
|
| Niklason Laura E |
President, CEO and Director |
• • • |
2021-12-15 |
4 |
S |
$8.89 |
$1,110,625 |
I/I |
(125,000) |
585,161 |
|
18% |
|
| Dougan Brady W |
Director |
– • • |
2021-12-14 |
4 |
S |
$9.33 |
$943,707 |
D/D |
(100,000) |
710,161 |
|
19% |
|
| Niklason Laura E |
President, CEO and Director |
• • • |
2021-12-14 |
4 |
S |
$9.33 |
$943,707 |
I/I |
(100,000) |
710,161 |
|
19% |
|
| Constantino Michael T. |
Director |
– • – |
2021-11-22 |
4 |
B |
$10.79 |
$26,986 |
D/D |
2,500 |
2,500 |
2.39 |
-34% |
|
| Fresenius Medical Care Holdings Inc /ny/ |
10% Owner |
– – • |
2021-08-26 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
18,312,735 |
|
-48% |
|
| Niklason Laura E |
President, CEO and DirectorOff |
• • • |
2021-08-26 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
810,161 |
|
-48% |
|
| Tente William Edward |
Chief Regulatory Officer |
• – – |
2021-08-26 |
4 |
A |
$0.00 |
$0 |
D/D |
52,519 |
52,519 |
|
- |
|
56 Records found
|
|
Page 2 of 3 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
0.48 (12.24%) 
